These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 19501141)

  • 1. Direct nose-to-brain transfer of a growth hormone releasing neuropeptide, hexarelin after intranasal administration to rabbits.
    Yu H; Kim K
    Int J Pharm; 2009 Aug; 378(1-2):73-9. PubMed ID: 19501141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(ethylene oxide/propylene oxide) copolymer thermo-reversible gelling system for the enhancement of intranasal zidovudine delivery to the brain.
    Ved PM; Kim K
    Int J Pharm; 2011 Jun; 411(1-2):1-9. PubMed ID: 21356294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and brain uptake of diazepam after intravenous and intranasal administration in rats and rabbits.
    Kaur P; Kim K
    Int J Pharm; 2008 Nov; 364(1):27-35. PubMed ID: 18760341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration.
    Thorne RG; Pronk GJ; Padmanabhan V; Frey WH
    Neuroscience; 2004; 127(2):481-96. PubMed ID: 15262337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of nimodipine in brain following intranasal administration in rats.
    Zhang QZ; Jiang XG; Wu CH
    Acta Pharmacol Sin; 2004 Apr; 25(4):522-7. PubMed ID: 15066224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nose-to-brain delivery of tacrine.
    Jogani VV; Shah PJ; Mishra P; Mishra AK; Misra AR
    J Pharm Pharmacol; 2007 Sep; 59(9):1199-205. PubMed ID: 17883890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the distribution of breviscapine in the brain by different administration routes].
    Shi SL; Xu LY; Wu JJ; Li CY; Ge WH; Dai WY
    Yao Xue Xue Bao; 2009 May; 44(5):515-8. PubMed ID: 19618729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfer of morphine along the olfactory pathway to the central nervous system after nasal administration to rodents.
    Westin U; Piras E; Jansson B; Bergström U; Dahlin M; Brittebo E; Björk E
    Eur J Pharm Sci; 2005 Apr; 24(5):565-73. PubMed ID: 15784346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain distribution of ribavirin after intranasal administration.
    Colombo G; Lorenzini L; Zironi E; Galligioni V; Sonvico F; Balducci AG; Pagliuca G; Giuliani A; Calzà L; Scagliarini A
    Antiviral Res; 2011 Dec; 92(3):408-14. PubMed ID: 22001322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug brain distribution following intranasal administration of Huperzine A in situ gel in rats.
    Zhao Y; Yue P; Tao T; Chen QH
    Acta Pharmacol Sin; 2007 Feb; 28(2):273-8. PubMed ID: 17241531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct transport of VEGF from the nasal cavity to brain.
    Yang JP; Liu HJ; Cheng SM; Wang ZL; Cheng X; Yu HX; Liu XF
    Neurosci Lett; 2009 Jan; 449(2):108-11. PubMed ID: 18996442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of baicalin-phospholipid complex in rat plasma and brain tissues after intranasal and intravenous administration.
    Li N; Je YJ; Yang M; Jiang XH; Ma JH
    Pharmazie; 2011 May; 66(5):374-7. PubMed ID: 21699072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on brain targeting of raltitrexed following intranasal administration in rats.
    Wang D; Gao Y; Yun L
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):97-104. PubMed ID: 16028105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel vasoconstrictor formulation to enhance intranasal targeting of neuropeptide therapeutics to the central nervous system.
    Dhuria SV; Hanson LR; Frey WH
    J Pharmacol Exp Ther; 2009 Jan; 328(1):312-20. PubMed ID: 18945930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic behavior of huperzine A in plasma and cerebrospinal fluid after intranasal administration in rats.
    Wang Q; Chen G
    Biopharm Drug Dispos; 2009 Dec; 30(9):551-5. PubMed ID: 19780094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain.
    Zhang Q; Jiang X; Jiang W; Lu W; Su L; Shi Z
    Int J Pharm; 2004 May; 275(1-2):85-96. PubMed ID: 15081140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of 125I-cobrotoxin after intranasal administration to the brain: a microdialysis study in freely moving rats.
    Li F; Feng J; Cheng Q; Zhu W; Jin Y
    Int J Pharm; 2007 Jan; 328(2):161-7. PubMed ID: 17049426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics and disposition of hexarelin, a peptidic growth hormone secretagogue, in rats.
    Roumi M; Marleau S; du Souich P; Maggi T; Deghenghi R; Ong H
    Drug Metab Dispos; 2000 Jan; 28(1):44-50. PubMed ID: 10611139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct olfactory transport of inhaled manganese ((54)MnCl(2)) to the rat brain: toxicokinetic investigations in a unilateral nasal occlusion model.
    Brenneman KA; Wong BA; Buccellato MA; Costa ER; Gross EA; Dorman DC
    Toxicol Appl Pharmacol; 2000 Dec; 169(3):238-48. PubMed ID: 11133346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of brain-targeting for the nasal delivery of estradiol by the microdialysis method.
    Wang X; He H; Leng W; Tang X
    Int J Pharm; 2006 Jul; 317(1):40-6. PubMed ID: 16631329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.